AJP - Heart and Circulatory Physiology, Vol 261, Issue 3 632-H638, Copyright © 1991 by American Physiological Society

ARTICLES

Correlation between antioxidant changes during hypoxia and recovery on reoxygenation

H. Dhaliwal, L. A. Kirshenbaum, A. K. Randhawa and P. K. Singal
Cardiovascular Sciences Division, St. Boniface General Hospital Research Center, Winnipeg, Manitoba, Canada.

Changes in myocardial antioxidants due to different durations of hypoxia at normal or lower temperatures were correlated with the recovery of structure and function on reoxygenation. Hearts perfused with substrate-free hypoxic buffer at 37 degrees C for 5 or 10 min and at 22 degrees C for 10 min showed a significant depression in the contractile function and rise in resting tension. Reoxygenation of these hearts at 37 degrees C for 20 min resulted in a recovery of these functions. On reoxygenation, hearts made hypoxic for 10 min at 37 degrees C showed poor recovery of the contractile function, increase in malondialdehyde content and a dramatic increase in the creatine phosphokinase activity in the coronary effluent. Addition of catalase to the perfusion medium markedly improved function recovery of these hearts. Hypoxia at 37 degrees C for 5 min or at 22 degrees C for 10 min with or without reoxygenation had no effect on superoxide dismutase (SOD) or glutathione peroxidase (GSHPx) activities. These antioxidants were depressed in hearts made hypoxic for 10 min at 37 degrees C with no further change on reoxygenation. Neither SOD nor GSHPx was detected in the coronary effluent during hypoxia or reoxygenation. Hypoxia at 37 or 22 degrees C for 10 min caused significant ultrastructural changes, and on reoxygenation 37 degrees C hypoxic hearts showed exacerbation, whereas the 22 degrees C hypoxic hearts showed recovery. These data support the hypothesis that reduced antioxidant reserve during hypoxia may contribute to the oxidative injury on reoxygenation, suggesting that maintenance of endogenous antioxidant levels during hypoxia may be important for recovery.

This article has been cited by other articles:

				Y. Suematsu, T. Ohtsuka, H. Horimoto, K. Maeda, Y. Nakai, S. Mieno, and S. Takamoto Long-term treatment with nipradilol, a nitric oxide-releasing {beta}-adrenergic blocker, enhances postischemic recovery and limits infarct size Ann. Thorac. Surg., January 1, 2002; 73(1): 173 - 179. [Abstract] [Full Text] [PDF]

				M. E Keith, K. N Jeejeebhoy, A. Langer, R. Kurian, A. Barr, B. O'Kelly, and M. J Sole A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure Am. J. Clinical Nutrition, February 1, 2001; 73(2): 219 - 224. [Abstract] [Full Text] [PDF]

				K. Ihnken, A. Winkler, C. Schlensak, K. Sarai, G. Neidhart, U. Unkelbach, A. Mulsch, and A. Sewell Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 327 - 331. [Abstract] [Full Text] [PDF]

				D. Yucel, S. Aydogdu, S. Cehreli, G. Saydam, H. Canatan, M. Senes, B. C. Topkaya, and S. Nebioglu Increased oxidative stress in dilated cardiomyopathic heart failure Clin. Chem., January 1, 1998; 44(1): 148 - 154. [Abstract] [Full Text] [PDF]

				K. Nakanishi, M. Inoue, E. Sugawara, and S. Sano ISCHEMIC AND REPERFUSION INJURY OF CYANOTIC MYOCARDIUM IN CHRONIC HYPOXIC RAT MODEL: CHANGES IN CYANOTIC MYOCARDIAL ANTIOXIDANT SYSTEM J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1088 - 1096. [Abstract] [Full Text]